OMX Nordic 40
2.412,36
PKT
+56,32
PKT
+2,39
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.05.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.05.21 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 11.05.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.05.21 | AstraZeneca buy | Deutsche Bank AG | |
| 11.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 11.05.21 | ABB (Asea Brown Boveri) buy | Goldman Sachs Group Inc. | |
| 10.05.21 | Kone Neutral | Goldman Sachs Group Inc. | |
| 07.05.21 | AstraZeneca buy | UBS AG | |
| 07.05.21 | Nokia overweight | Morgan Stanley | |
| 07.05.21 | Kone Equal-Weight | Morgan Stanley | |
| 06.05.21 | Novo Nordisk Neutral | Credit Suisse Group | |
| 06.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.05.21 | A.P. Moeller - Maersk A-S (B) buy | Deutsche Bank AG | |
| 06.05.21 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
| 06.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.21 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.05.21 | Volvo (B) Sell | UBS AG | |
| 05.05.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 05.05.21 | Novo Nordisk overweight | Barclays Capital | |
| 05.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.05.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 04.05.21 | AstraZeneca buy | Deutsche Bank AG | |
| 03.05.21 | AstraZeneca buy | Kepler Cheuvreux | |
| 03.05.21 | AstraZeneca Verkaufen | DZ BANK | |
| 03.05.21 | Kone Outperform | Credit Suisse Group | |
| 03.05.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.04.21 | AstraZeneca buy | UBS AG | |
| 30.04.21 | AstraZeneca buy | Jefferies & Company Inc. | |
| 30.04.21 | Nokia buy | Deutsche Bank AG | |
| 30.04.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.04.21 | Kone Underperform | RBC Capital Markets | |
| 29.04.21 | Kone Sell | UBS AG | |
| 29.04.21 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 29.04.21 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 28.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.04.21 | Kone Neutral | Goldman Sachs Group Inc. | |
| 28.04.21 | Kone Underperform | RBC Capital Markets | |
| 28.04.21 | Kone Underperform | Jefferies & Company Inc. | |
| 28.04.21 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group |